Julian Schink
机构: Cancer Treatment Centers of America
每年引用次数
引用次数
引用: 6,544
H-指数: 46
I10-指数 : 96
出版物: 239
Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: an Eastern Cooperative Oncology Group Phase II Study (E2E93).
Falkson C , Cella D , Harris Ls , Gerstner J
Cancer Journal 7 ( 2) 155 -164
18
2001
Ovarian carcinoma metastatic to the breast and axillary node.
August Cz , Duda Rb , Schink Jc
Surgery 110 ( 3) 552 -556
22
1991
Synergistic effect of combined intraperitoneal cisplatin and cytosine arabinoside in a murine ovarian cancer model.
Berek Js , Knox Rm , Schink Jc
Obstetrics & Gynecology 74 ( 4) 663 -666
10
1989
Current initial therapy of stage III and IV ovarian cancer: challenges for managed care.
Schink Jc
Seminars in Oncology 26 ( 1) 2 -7
36
1999
Laser vaporization versus laser excision conization in the treatment of cervical intraepithelial neoplasia.
Julian C Schink ,
Obstetrics & Gynecology 74 ( 4) 681
1989
Paclitaxel, carboplatin, and hexamethyl-melamine (taxchex) as first-line therapy for ovarian cancer.
E. Larrison , L. S. Harris , H. H. Bailey , Ellen M. Hartenbach
The cancer journal from Scientific American 5 ( 6) 348 -355
2
1999
Managing the care of patients with advanced ovarian cancer.
J. C. Schink
Seminars in Oncology 26 ( 1) 59 -61
4
1999
Saline contrast sonohysterography and directed extraction, resection and biopsy of intrauterine pathology using a Uterine Explora Curette
AY Wei , JC Schink , EA Pritts , DL Olive
Ultrasound in Obstetrics & Gynecology 27 ( 2) 202 -205
11
2006
Phase II trial of weekly docetaxel and carboplatin for recurrent ovarian and peritoneal cancer: Preliminary results including prevention of carboplatin hypersensitivity
D. M. Kushner , E. M. Hartenbach , F. Sanchez , J. C. Schink
Journal of Clinical Oncology 22 5041 -5041
2004
Weekly topotecan for platinum resistant ovarian cancer
F. Abushahin , E. C. Grendys , J. R. Lurain , D. K. Singh
Journal of Clinical Oncology 24 15040 -15040
2006
Outpatient intraperitoneal chemotherapy for ovarian cancer chemotherapy—A comparison of reimbursement for intraperitoneal versus intravenous therapy
J. C. Schink , T. Bamlett-Sherman , L. M. Anastos
Journal of Clinical Oncology 25 16027 -16027
2007
Prophylactic oophorectomy for patients with breast cancer with BRCA results.
J. C. Schink , K. M. Doll , C. B. Weldon , J. R. Trosman
Journal of Clinical Oncology 29 1533 -1533
1
2011
The association between allogeneic perioperative blood transfusion on tumour recurrence and survival in patients with advanced ovarian cancer
G. S. De Oliveira , J. C. Schink , C. Buoy , S. Ahmad
Transfusion Medicine 22 ( 2) 97 -103
82
2012
Outpatient vaginal cuff brachytherapy for endometrial cancer
D. G. Petereit , S. P. Tannehill , E. A. Grosen , E. M. Hartenbach
International Journal of Gynecological Cancer 9 ( 6) 456 -462
68
1999
BRCA+ test result impact and timing on surgical treatment decisions for patients with breast cancer.
K. M. Doll , C. B. Weldon , J. R. Trosman , H. H. Wetzel
Journal of Clinical Oncology 29 626 -626
1
2011
Barriers to implementing primary HER2 FISH testing.
G. J. Tsongalis , C. B. Weldon , J. R. Trosman , W. J. Gradishar
Journal of Clinical Oncology 29
2
2011
Oncology Medical Home to address challenges in breast cancer care delivery.
J. R. Trosman , C. B. Weldon , A. B. Benson , W. J. Gradishar
Journal of Clinical Oncology 29
2011
Facilitators of quality breast cancer screening and diagnosis in an urban environment.
C. B. Weldon , J. R. Trosman , D. Dupuy , R. Alvarez
Journal of Clinical Oncology 29
2011
Care delivery barriers to personalized medicine in breast cancer.
J. C. Schink , C. B. Weldon , J. R. Trosman , A. B. Benson
Journal of Clinical Oncology 28 6146 -6146
2010
Timing of genetic testing relative to breast cancer surgery.
J. R. Trosman , C. B. Weldon , W. J. Gradishar , J. C. Schink
Journal of Clinical Oncology 28 ( 15_suppl) 666 -666
1
2010